Editing Microreactor (section)

==Market structure==
{{unreferenced section|date=June 2021}}
[[File:FlowStart CloseUp.jpg|thumb|Example of a flow reactor system]]
The market for microreactors can be segmented based on customer objectives, into turnkey, modular, and bespoke systems.

Turnkey (ready to run) systems are being used where the application environment stands to benefit from new chemical synthesis schemes, enhanced investigational throughput of up to approximately 10 - 100 experiments per day (depends on reaction time) and reaction subsystem, and actual synthesis conduct at scales ranging from 10 [[milligram]]s per experiment to triple digit tons per year (continuous operation of a reactor battery).

Modular (open) systems are serving the niche for investigations on continuous process engineering lay-outs, where a measurable process advantage over the use of standardized equipment is anticipated by chemical engineers. Multiple process lay-outs can be rapidly assembled and chemical process results obtained on a scale ranging from several grams per experiment up to approximately 100&nbsp;kg at a moderate number of experiments per day (3-15). A secondary transfer of engineering findings in the context of a plant engineering exercise (scale-out) then provides target capacity of typically single product dedicated plants. This mimics the success of engineering contractors for the petro-chemical process industry.

With dedicated developments, manufacturers of microstructured components are mostly commercial development partners to scientists in search of novel synthesis technologies. Such development partners typically excel in the set-up of comprehensive investigation and supply schemes, to model a desired contacting pattern or spatial arrangement of matter. To do so they predominantly offer information from proprietary integrated modeling systems that combine computational fluid dynamics with thermokinetic modelling. Moreover, as a rule, such development partners establish the overall application analytics to the point where the critical initial hypothesis can be validated and further confined.